罗氏周一表示，将在马德里举行的ESMO 2026癌症会议上公布新的晚期临床试验结果，包括显示其肺癌药物迪瓦拉西布疗效优于目前KRAS G12C治疗的数据。
Roche said on Monday it will present new late-stage trial results at the ESMO 2026 cancer meeting in Madrid, including data showing its lung cancer drug divarasib worked better than current KRAS G12C treatments.
该公司还将展示其乳腺癌药物吉瑞德斯坦的数据，表明该药在不损害患者生活质量的情况下改善了预后，以及其实验性药物Tam-Peli在多种难治性肿瘤中取得了强劲疗效。
The company will also show data that its breast cancer pill giredestrant improved outcomes without hurting patients' quality of life, and that its experimental drug Tam-Peli showed strong results in several hard-to-treat tumours.